A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin
The H7N9 influenza virus causes high-mortality disease in humans but no effective therapeutics are available. Here we report a human monoclonal antibody, m826, that binds to H7 hemagglutinin (HA) and protects against H7N9 infection. m826 binds to H7N9 HA with subnanomolar affinity at acidic pH and 1...
Saved in:
Published in | Cell host & microbe Vol. 22; no. 4; pp. 471 - 483.e5 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
11.10.2017
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The H7N9 influenza virus causes high-mortality disease in humans but no effective therapeutics are available. Here we report a human monoclonal antibody, m826, that binds to H7 hemagglutinin (HA) and protects against H7N9 infection. m826 binds to H7N9 HA with subnanomolar affinity at acidic pH and 10-fold lower affinity at neutral pH. The high-resolution (1.9 Å) crystal structure of m826 complexed with H7N9 HA indicates that m826 binds an epitope that may be fully exposed upon pH-induced conformational changes in HA. m826 fully protects mice against lethal challenge with H7N9 virus through mechanisms likely involving antibody-dependent cell-mediated cytotoxicity. Interestingly, immunogenetic analysis indicates that m826 is a germline antibody, and m826-like sequences can be identified in H7N9-infected patients, healthy adults, and newborn babies. These m826 properties offer a template for H7N9 vaccine immunogens, a promising candidate therapeutic, and a tool for exploring mechanisms of virus infection inhibition by antibodies.
[Display omitted]
•Identification of human germline monoclonal antibody (m826) that binds H7N9 HA•Structure of H7N9 HA complexed with m826 antibody•Antibody recognizes a pH-sensitive epitope within H7N9 HA•Antibody fully protects mice against lethal challenge with H7N9 virus
H7N9 influenza virus causes high-mortality disease in humans. Yu et al. identify a human germline monoclonal antibody recognizing a pH-sensitive epitope on H7N9 hemagglutinin globular head. This antibody is effective against H7N9 influenza in vivo, likely due to ADCC activity, and may facilitate the development of prophylactics and therapeutics. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 USDOE Office of Science (SC), Basic Energy Sciences (BES) W-31-109-Eng-38 Lead Contact These authors contributed equally |
ISSN: | 1931-3128 1934-6069 |
DOI: | 10.1016/j.chom.2017.08.011 |